Manufacturing in Ireland has long helped many American drug companies pay lower taxes. But that strategy was designed for a ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

Pharmaceutical research and development firms in China are increasingly interested in procuring critical supplies known as ...

Germany’s Merck KGaA (MRK: DE) has reported second quarter earnings that missed analyst expectations. The life sciences company’s earnings before interest, taxes, depreciation and amortization (EBITDA ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst ...

The Institute for Deep Tech Innovation (DEEP) at ESMT Berlin and Merck are joining forces to establish a leading innovation ...

The force between electrical charges is kind of a big deal—without it, the universe would be a primordial soup and you would ...

Merck said in March it plans to spend $1 billion on a plant in Delaware that would manufacture biologic drugs and a new, easier-to-use version of Keytruda, marking the company's first in-house ...

To meet growing demand and support biologics innovation, Merck & Co., Inc. (NYSE:MRK) began construction of a $1 billion Biologics Center of Excellence in Wilmington, Delaware, in April 2025.

AI cloud firm CoreWeave is buying an entire tech and life science campus where it previously leased a single data center.

After decades of limited progress—owing to the difficulty of treating the disease and resultant market risk—glioblastoma ...

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of novel immunotherapies by applying its proprietary technologies to its Tumor ...